Calcium Gluconate Compatibility and Administration Guidelines

Dilution and Compatibility

Sterile normal saline (0.9% sodium chloride) with or without 0.4% phenol may be used as the diluent for preparing calcium gluconate solutions in parenteral nutrition, as recommended by the American Society for Parenteral and Enteral Nutrition 1
Calcium gluconate packed in polyethylene (rather than glass vials) is recommended to reduce aluminum contamination when preparing parenteral nutrition solutions with normal saline, according to the European Society for Clinical Nutrition and Metabolism 2, 3, 4

Never administer sodium bicarbonate and calcium through the same IV line, as advised by the American Heart Association 5
When calcium and phosphate must both be included in parenteral nutrition, add calcium salts to amino acids and glucose first, then add phosphate salts at the end of the compounding process to minimize precipitation risk, as recommended by the American Society for Parenteral and Enteral Nutrition 2, 4
Calcium gluconate is preferred over calcium chloride for peripheral IV administration because it causes less tissue irritation and has lower risk of extravasation injury, according to the American College of Clinical Pharmacy 5

The ESPGHAN/ESPEN/ESPR/CSPEN guidelines strongly recommend using organic calcium and phosphate salts for compounding PN solutions to prevent precipitation, and calcium gluconate and potassium chloride can be safely combined in parenteral nutrition formulations when proper compounding techniques are followed 6, 7.

In individualized PN, especially when calcium and phosphate intakes at the upper range are used, stability and compatibility must be tested by the local pharmacy to avoid precipitation risk, as recommended by the ESPGHAN/ESPEN/ESPR/CSPEN guidelines 6, 7.

Blood concentrations and urine output require periodic monitoring during PN administration, and in individualized PN formulations, local pharmacy testing of stability, compatibility, and solubility of minerals is essential 6, 7.

The ESPGHAN/ESPEN/ESPR/CSPEN guidelines recommend avoiding the use of acidic calcium gluconate solutions packaged in glass vials for PN, as they are contaminated with aluminum 6, 7.